TSPO PET scan study for people with tumors
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a special PET scan that looks at a protein called TSPO, which may be active in tumors. It may help doctors understand and monitor certain cancers better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a suspected or known malignant tumor (cancer)
- You are scheduled for a TSPO PET/CT scan
- You are able to give informed consent (or have a parent or legal representative who can)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.
This study uses a special type of brain scan (PET/CT) to look at a protein called MAO-B in people with Parkinson's disease or related conditions. The scan may help doctors understand more about the disease and could be part of your regular care.
This study uses a special type of PET scan (called SSTR PET/CT) to look at tumors that may have a specific receptor. The scan helps doctors see where these tumors are and how active they are.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This trial tests a new radioactive imaging agent that targets a protein (TSPO) in the brain, which is linked to inflammation. The goal is to see if it can help visualize brain inflammation in people with Alzheimer's disease, potentially aiding in diagnosis and monitoring.
This trial looks at brain inflammation in people with Parkinson’s using a special PET scan. The goal is to understand how brain immune activity may relate to Parkinson’s, and how the scan results change over time.
Hear when a new Neuroinflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.